This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Hormone measurements

Authoring team

The most important measurements are serum LH, FSH, PRL (x2) and TFTs.

LH is often raised in polycystic ovarian syndrome.

An elevated serum FSH indicates ovarian failure.

Prolactin is raised by stress, prolactinomas and secondary to some drugs e.g. phenothiazines.

A normal FSH may occur in conditions such as PCO, hypothalamic - pituitary lesions, and outflow tract disorders. A progesterone challenge will help discriminate these conditions. A withdrawal bleed after a progesterone challenge indicates anovulation e.g. PCO. No withdrawal bleed after a regime of oestrogen for 21 days then progestogen for 5 days indicates an outflow tract disorder e.g. Asherman's syndrome. A withdrawal bleed will occur after endometrial stimulation with oestrogens then a progestogen if there is a hypothalamic - pituitary lesion.

Measurement of plasma testosterone is indicated in amenorrhoea associated with hirsutism. Levels greater than 6 nmol/litre suggest ovarian malignancy which must be investigated further. An elevated LH/FSH ration with raised testosterone - but less than 6 nmol/litre - suggests polycystic ovarian syndrome.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.